key: cord-0728955-axm7i3fh
authors: Montano, Mauricio; Victor, Andrea R.; Griffin, Darren K.; Duong, Tommy; Bolduc, Nathalie; Farmer, Andrew; Garg, Vidur; Hadjantonakis, Anna-Katerina; Barnes, Frank L.; Zouves, Christo G.; Greene, Warner C.; Viotti, Manuel
title: Human Pre-Implantation Embryos Are Permissive to SARS-CoV-2 Entry
date: 2021-01-21
journal: bioRxiv
DOI: 10.1101/2021.01.21.427501
sha: 7a5c3b47779f7f1a8cb1548d4a60d921af2c1c8b
doc_id: 728955
cord_uid: axm7i3fh

Vertical transmission of SARS-CoV-2, the virus responsible for COVID-19, from parents to early embryos during conception could be catastrophic, but is contingent on the susceptibility of cells of the embryo to infection. Because presence of the SARS-CoV-2 virus has been reported in the human reproductive system, we assessed whether pre-implantation embryos are permissive to SARS-CoV-2 entry. RNA-seq and immunostaining studies revealed presence of two key entry factors in the trophectoderm of blastocyst-stage embryos, the ACE2 receptor and the TMPRSS2 protease. Exposure of blastocysts to fluorescent reporter virions pseudotyped with the SARS-CoV-2 Spike (S) glycoprotein revealed S-ACE2 dependent entry and fusion. These results indicate that human pre-implantation embryos can be infected by SARS-CoV-2, a finding pertinent to natural human conceptions and assisted reproductive technologies during and after the COVID-19 pandemic.

Coronavirus disease 2019 (COVID-19) has emerged as an unexpected, novel, and devastating pandemic upending life around the globe 1 . Entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infectious agent responsible for COVID-19 2 , requires interactions of its surface glycoprotein Spike (S) with two 'entry' factors on the target cell: engagement of the receptor angiotensin-converting enzyme 2 (ACE2) by S and cleavage of S by the serine protease TMPRSS2 3, 4 . These binding and processing steps lead to subsequent endocytosis of virions and fusion within the late endosome 4 .

The full repertoire of cell and tissue types that SARS-CoV-2 can infect is now being defined 1, 5 . Expression of SARS-CoV-2 cell entry factors has been described in a wide assortment of human cells 5 , and in COVID-19 patients, SARS-CoV-2 virus has been detected in various organs [6] [7] [8] . Infected individuals can also exhibit a range of symptoms spanning beyond lung-related problems, to include disease in the intestine, heart, kidney, vasculature, and liver 6, [8] [9] [10] [11] [12] . Within the female and male reproductive systems, expression of SARS-CoV-2 entry factors is present in cells of the ovaries, uterus, vagina, testis, and prostate 5, [13] [14] [15] [16] . The virus is also detectable in the semen of infected males 17 .

The possibility of vertical transmission of SARS-CoV-2 to embryos during or shortly after fertilization is concerning, but is contingent on cells of the embryo being permissive to the virus. We now confirm expression of key entry factors for SARS-CoV-4 virions pseudotyped with SARS-CoV-2 S can successfully enter cells of the embryo through S binding to ACE2 receptors.

All embryos used in this study were surplus samples from fertility treatment and in vitro fertilization, donated strictly for research by signed informed consent. Ethical approval for this project was obtained through the IRB of the Zouves Foundation for Reproductive Medicine (OHRP IRB00011505). For the RNA-seq experiment, embryos were of various ethnic backgrounds and comprised a mix of euploid and aneuploid samples based on evaluation by pre-implantation genetic testing for aneuploidy (PGT-A) 18 (Suppl. Table   1 ). For immunofluorescence and infection experiments, embryos were either untested or assessed by PGT-A, and included a mix of euploid, mosaic, and aneuploid samples (samples with aneuploidies in chromosomes X or 21, respectively encoding ACE2 and TMPRSS2, were excluded).

Trophectoderm (TE) biopsies containing 5-10 cells from blastocyst-stage embryos (n=24) were processed for RNA-seq using a commercial kit (Takara Bio, SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing) following the user manual. The resulting cDNAs were converted to libraries using Illumina Nextera XT kit (with modified protocol according to SMART-Seq v4 user manual). The resulting libraries were pooled and sequenced on an Illumina NextSeq 550 with a MidOutput cartridge at 2x75 cycles. The sequencing reads in Fastq files were down-sampled to 6M total reads, aligned to the human genome assembly (hg38), and the number of transcripts per million (TPM) was determined using the CLC Genomics Workbench 12 (Qiagen). Results were mined for expression of factors implicated in SARS-CoV-2 infection. Violin plots were prepared with PlotsOfData 19 .

Blastocysts were immersed in fixation buffer containing 4% paraformaldehyde (EMS no. 15710) and 10% fetal bovine serum (FBS; Seradigm 1500-050) in phosphate-buffered saline (PBS; Corning MT21040CM) for 10 minutes (min) at room temperature (rt), followed by three 1-min washes at rt in PBS with 10% FBS. Embryos were blocked in 2% horse serum (Sigma H0146) and 0.1% saponin (Sigma S7900) in PBS (blocking solution) for 1 hour (h) at rt and then incubated with primary antibodies diluted in blocking solution overnight at 4 °C. Embryos were then washed three times for 5 min each in PBS at rt prior to incubation with secondary antibodies. Secondary antibodies diluted in blocking solution were applied for 1 h at 4 °C. Embryos were then washed twice for 5 min each in PBS and subsequently incubated with 5 µg/ml Hoechst 33342 (Invitrogen) in PBS for 5 min. Finally, embryos were washed twice for 5 min each in PBS prior to mounting for imaging. The following primary antibodies were used: goat anti-ACE2 (R&D Systems AF933, 1:100), mouse anti-TMPRSS2 (Developmental Hybridoma Bank P5H9-A3, 3.2 µg/ml). The following secondary Alexa Fluor-conjugated antibodies (Invitrogen) were used at a dilution of 1:500: donkey anti-goat Alexa Fluor 568 (A10042), donkey anti-mouse Alexa Fluor 488 (A21202). DNA was visualized using Hoechst 33342. For all immunofluorescence experiments, n = 5 independent biological replicates were used.

For production of HIV-1 NL-43∆Env-eGFP SARS CoV-2 S pseudotyped virus particles, 293T cells were plated at 3.75 x10 6 Embryos were simultaneously scanned for Hoechst and GFP using the 405-nm and 488-nm lasers. RapidZ series were taken through the entire volume of the imaged embryos in 3 µm steps.

We reasoned that within the pre-implantation period of human development, embryos in the blastocyst stage are particularly vulnerable as they lose their protective zona pellucida (ZP) that counters the threat of many foreign agents 20 . The trophectoderm, which is the precursor to the the placenta 21 , is located at the surface of the blastocyst and may be the specific target of infecting viruses. Hence, we focused our attention on the trophectoderm and evaluated its permissiveness to SARS-CoV-2 infection. Table 1 ). ACE2 transcripts were detected in trophectoderm biopsies comprising 5-10 cells in 23 of 24 embryos (95.8%), and TMPRSS2 transcripts in biopsies from all 24 embryos (Fig.1A) . We evaluated the expression of 22 additional human genes proposed to be involved in the SARS-CoV-2 life cycle 5 (Fig.1B) .

Expression was confirmed for genes encoding putative alternate receptors (BSG/CD147, ANPEP) and proteases (CTSB, CTSL, TMPRSS4). Transcripts for DPP4, encoding the receptor used by MERS-CoV to enter cells, were either absent or expressed at very low levels in our samples.

Genes for two factors apparently required for SARS-CoV-2 genome replication, TOP3B and ZCRB1/MADP1, were expressed respectively at low and high levels.

Among the genes encoding factors proposed to control trafficking and/or assembly of viral components and which are known to interact with SARS-CoV-2 proteins, RHOA, RAB10, RAB14, RAB1A, AP2M1, and CHMP2A exhibited high levels of expression while AP2A2 and TAPT1 were expressed at low levels. Together, these transcriptomic profiling data indicate that trophectoderm cells express many key factors required for SARS-CoV-2 entry and subsequent replication.

To evaluate the presence and localization of entry factors in trophectoderm cells, we performed immunofluorescence and confocal imaging for ACE2 and TMPRSS2 in blastocysts. Both factors were readily detectable in cells of the trophectoderm; ACE2 was enriched on cellular membranes, as evidenced by strong signal at cell-cell junctions ( Fig. 2A) , while the TMPRSS2 pattern was more diffuse, localizing to both cell membranes and within the cytoplasm but not nucleus (Fig. 2B) . The inner cell mass (ICM) was not evaluated, since the immunofluorescence protocol was not optimized for penetration of antibodies through cell layers. Localization of ACE2 and TMPRSS2 protein suggests that pre-implantation embryos are potentially permissive to SARS-CoV-2 entry.

To test the susceptibility of embryos to SARS-CoV-2 infection, we evaluated the entry of viral agents expressing the SARS-CoV-2 S protein. In the first series of experiments (see Table 1 ), we used an HIV-based reporter virion lacking its native viral entry factor Env, and encoding the green fluorescent protein (GFP). Embryos exposed to control media or media containing the original non-pseudotyped 'bald' reporter virus displayed no fluorescence and appeared healthy 24-48 hours after mock spinoculation (inoculation by centrifugation) (Suppl. Fig. 1) . However, when embryos were exposed to the reporter virus pseudotyped with the S protein from SARS-CoV-2, several showed robust GFP signal in numerous trophectoderm cells (Fig. 3A) . Some embryos showed both strong GFP signal and evidence of cell degradation (Fig.3A and Suppl. Fig. 1) .

GFP fluorescence to a limited number of puncta (Suppl. Fig. 1 ).

In the second experimental series (see Table 1 ), we used a vesicular stomatitis virus lacking the cell entry factor G envelope protein (VSV∆G), and encoding GFP as a reporter. No fluorescence was detected when embryos were exposed to control media or media containing the non-pseudotyped 'bald' virions . Conversely, several samples exhibited GFP when exposed to the reporter virus pseudotyped with the SARS-CoV-2 S protein (Fig. 3B) . Again, some of the infected embryos showed evidence of cellular degradation 24-48 h after spinoculation (Fig. 3B and Suppl. Fig. 1) . Addition of a neutralizing antibody targeting either S or ACE2 strongly reduced GFP expression, while a control, non-specific anti-IgG antibody produced no inhibitory effects (Suppl. . 1) . When the VSV∆G-based reporter virus was pseudotyped with the S protein from SARS-CoV-1, which also utilizes the ACE2 receptor for cell entry, embryos again displayed GFP signal and occasional evidence of cellular degradation (Suppl. Fig. 1) .

Conversely, reporter virus pseudotyped with the S protein from MERS-CoV, which depends on the dipeptidyl peptidase 4 (DPP4) receptor for cell entry, produced no GFP signal (Suppl. Fig. 1) . Together, these pseudotyped-virion experiments indicate that pre-implantation embryos are permissive to SARS-CoV-2 entry (and likely SARS-CoV-1 entry), involving interactions of S proteins with the ACE2 receptor.

The findings of this study demonstrate the permissiveness of human pre- 

Emerging Pandemic Diseases: How We Got to COVID-19

A Novel Coronavirus from Patients with Pneumonia in China

A pneumonia outbreak associated with a new coronavirus of probable bat origin

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2

A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors

Novel coronavirus infection and gastrointestinal tract

Multiorgan and Renal Tropism of SARS-CoV-2

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle

Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues

scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia

Potential influence of COVID-19/ACE2 on the female reproductive system

Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease

Preimplantation Genetic Testing for Chromosomal Abnormalities

Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?

Undetectable viral RNA in oocytes from SARS-CoV-2 positive women

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic

Assessment and management of the risk of SARS-CoV-2 infection in an IVF laboratory

Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE and IFFS

Navigating assisted reproduction treatment in the time of COVID-19: concerns and considerations

COVID-19 in pregnancy and the puerperium: A review for emergency physicians